RIL
PTLA

Rothschild Investment LLC’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Rothschild Investment LLC’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-19,851
Closed -$142K – 452
2020
Q1 		$142K Buy
19,851
+5,440
+38% +$67.9K 0.02% 393
2019
Q4 		$344K Buy
+14,411
New +$398K 0.03% 339
2019
Q3 		– Sell
-17,010
Closed -$461K – 397
2019
Q2 		$461K Hold
17,010
– – 0.05% 266
2019
Q1 		$590K Hold
17,010
– – 0.07% 229
2018
Q4 		$332K Buy
17,010
+4,900
+40% +$101K 0.04% 274
2018
Q3 		$322K Sell
12,110
-540
-4% -$17.6K 0.04% 288
2018
Q2 		$478K Buy
12,650
+320
+3% +$12.2K 0.06% 244
2018
Q1 		$403K Hold
12,330
– – 0.05% 261
2017
Q4 		$600K Sell
12,330
-8,550
-41% -$432K 0.07% 253
2017
Q3 		$1.13M Hold
20,880
– – 0.13% 183
2017
Q2 		$1.17M Buy
20,880
+1,370
+7% +$54.9K 0.13% 185
2017
Q1 		$765K Hold
19,510
– – 0.09% 221
2016
Q4 		$438K Sell
19,510
-5,230
-21% -$102K 0.05% 286
2016
Q3 		$562K Buy
24,740
+2,590
+12% +$60.8K 0.07% 249
2016
Q2 		$523K Buy
22,150
+3,130
+16% +$77.3K 0.07% 249
2016
Q1 		$388K Buy
+19,020
New +$603K 0.05% 302
2015
Q2 		– Sell
-17,114
Closed -$650K – 523
2015
Q1 		$650K Sell
17,114
-796
-4% -$27.3K 0.08% 257
2014
Q4 		$507K Hold
17,910
– – 0.06% 294
2014
Q3 		$453K Buy
17,910
+650
+4% +$17.1K 0.06% 313
2014
Q2 		$504K Hold
17,260
– – 0.06% 264
2014
Q1 		$447K Buy
+17,260
New +$461K 0.06% 288

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Rothschild Investment LLC's PTLA Position: Q2 2020 in Review

Rothschild Investment LLC sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 19,851 shares — an estimated $142K sold.

Rothschild Investment LLC first reported a position in PTLA in Q1 2014 and held it in 21 quarters. The position peaked at $1.17M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Rothschild Investment LLC reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Rothschild Investment LLC sold 19,851 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $142K.
  • Rothschild Investment LLC first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 21 quarters.
  • Rothschild Investment LLC's Portola Pharmaceuticals, Inc. position peaked at $1.17M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Rothschild Investment LLC's 13F filing for Q2 2020, filed 24 Jul 2020.